Balancing safety and immunogenicity in live-attenuated mycobacterial vaccines for use in humans at risk for HIV: Response to Misleading comments in Ranganathan et al. “Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice”

Saved in:
Bibliographic Details
Published inVaccine Vol. 28; no. 21; pp. 3633 - 3634
Main Authors Larsen, Michelle H, Jacobs, William R, Porcelli, Steven A, Kim, John, Ranganathan, Uma Devi K, Fennelly, Glenn J
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 07.05.2010
Elsevier Limited
Subjects
AIDS Vaccines - immunology
Allergy and Immunology
Animals
HIV - immunology
HIV Infections - prevention & control
Humans
Immunogenicity
Mice
Mice, SCID
Mycobacterium tuberculosis - immunology
Tuberculosis
Vaccines, Attenuated - immunology
Online AccessGet full text

Cover

More Information
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2010.03.025